Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Aerospace and defense operator The Boeing Co. ( BA - Analyst Report ) received an order to supply 16’ 737 MAX airplanes to IcelandAir. The initial order for 12 aircrafts was received in Dec 2012, which has been increased to 16 now. The agreement also includes purchase rights for another eight 737 MAXs.
The total value of the 16 airplanes will be $1.6 billion at list prices. We expect IcelandAir to get a discount on list prices as Boeing has historically offered discounts on bulk orders.
The bulging 737 MAX order book, which presently stands at 1,180 airplanes, will definitely offer a breather for this airplane manufacturer given the continued uncertainty over its Dreamliner 787 model. To cope with piling order, Boeing decided to increase its production rate of 737 MAX from the current 38 airplanes a month to 42 airplanes a month in 2014.
Boeing 737 MAX is a premier aircraft from Boeing’s stable and sees brisk demand in the single-aisle market for its fuel efficiency and low carbon dioxide emissions. Powered by the Commercial Fan Motor (“CFM”) International LEAP-1B engines, the Advanced Technology winglet of this airplane also enhances performance.
Additionally, the pivoting overhead stowage bins add to the spaciousness of the cabin. The bins give passengers more room to keep a carry-on roll-aboard near their own seat besides providing extra leg space. This aircraft is 13% more fuel efficient than its closest peer in the single-aisle aircraft market.
Despite a strong showing from 737 MAX, Boeing’s commercial aircraft division continues to face problems with its 787 Dreamliner. To begin with there were delays with the first 787 aircraft delivery. On Jan 16 this year all 787 Dreamliners were grounded worldwide after battery-related incidents. A parked 787 at the Logan International Airport in Boston caught fire while there was an in-flight incident on another 787 in Japan forcing an emergency landing. Boeing is investigating the cause of battery malfunction.
Boeing is yet to resolve its Dreamliner 787 battery problem though it continues to manufacture the model. However, supply of the same to its customers has been halted. We believe unless the company succeeds to solve the battery issue margins would come under pressure and eventually the company might find it difficult to meet its 2013 delivery target of 60’ 787 airplanes.
Boeing completed 2012 with a strong backlog of 4,400 airplanes valued at $319 billion. 737 MAX and the jinxed 787 model will play a pivotal role for the company in achieving its 2013 commercial revenue target which is in the range of $51 billion to $53 billion.
Boeing currently retains a Zacks Rank #3 (Hold). We presently prefer other operators in the aerospace and defense sector, like Huntington Ingalls Industries ( HII - Snapshot Report ) , Lockheed Martin Corporation ( LMT - Analyst Report ) , and Rockwell Collins Inc. ( COL - Analyst Report ) , all carrying a Zacks Rank #2 (Buy).
Read the full Analyst Report on BA
Read the full Analyst Report on COL
Read the full Analyst Report on LMT
Read the full Snapshot Report on HII